Improved Outcomes after Lower Limb Revascularization

Operator ability combined with improved and diverse devices for lower limb revascularization has clearly increased in the last decade. However, is this technical feasibility we did not use to have translating into better clinical outcomes for patients, or is it simply inflating our interventionist egos?

Mejorando los resultados luego de la revascularización de miembros inferiores

This study aims at answering the question above by identifying an astonishing 103934 patient population undergoing endovascular (endarterectomy) or surgical (profundaplasty or bypass) lower limb revascularization for infrainguinal peripheral artery disease between 2006 and 2015.

Major amputation and deaths within a year after procedure were registered and adjusted by age, sex, diabetes and other comorbidities, in addition to revascularization indication (Intermittent claudication, severe ischemia with tissue loss, severe ischemia with gangrene/osteomyelitis).

The risk of major amputation at one year after endovascular procedure dropped from 5.7% (2006-2007) to 3.9% (2014-2015). For surgical revascularization, risk dropped from 11.2% (2006-2007) to 6.6% (2014-2015).


Read also: Peri-Procedural Infarction in Angioplasty vs. Surgery in the Left Main Coronary Artery.


Mortality risk after both revisualization types also dropped over time. These trends were observed in all the clinical spectrum that justified revascularization indication, though the biggest benefit was in patients with severe ischemia and tissue loss or gangrene.

A curiosity observed over the years is increased morbidity, which could easily be explained by a larger proportion of patients treated at the end of their disease (sever ischemia with tissue los or gangrene) by less invasive methods.

Conclusion

These ten-year findings show an increase of survival rate and a reduction in major amputation after revascularization procedures. Outcomes have effectively improved hand in hand with experience and new devices, which justifies centralization and specialization of peripheral vascular centers.

Original Title: Improving 1-year Outcomes of Infrainguinal Limb Revascularisation: A Population-Based Cohort Study of 104 000 Patients in England.

Reference: Heikkila et al. Circulation. 2018 May 1;137(18):1921-1933.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

Su opinión nos interesa. Puede dejar su comentario, reflexión, pregunta o lo que desee aquí abajo. Será más que bienvenido.

More articles by this author

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....

Chronic Thromboembolic Pulmonary Hypertension: Treatment Outcomes According to a Worldwide Registry

Chronic thromboembolic pulmonary hypertension (CTEPH) is a highly limiting condition that, despite its moderate incidence, significantly impacts patient prognosis and quality of life. The...

Contemporary Outcomes of Acute Limb Ischemia Endovascular Revascularization

Acute limb ischemia (ALI) is a vascular emergency with high mortality rate. It has been defined as a sudden occlusion of limb perfusion compromising...

TCT 2024 | SIRONA: Randomized Study Comparing Sirolimus-Coated vs Paclitaxel-Coated Balloon Angioplasty in Femoropopliteal Disease

This prospective, randomized, multicenter, investigator-initiated non-inferiority study compared the use of sirolimus-coated balloon (MagicTouch) vs paclitaxel-coated balloon in endovascular treatment.  The primary objective was to...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Long Term Results of the International Chimney Registry

The International Chimney Registry was an observational study aimed at assessing the use of chimney stenting during TAVR either to predict or treat coronary...

CANNULATE TAVR extended study: Impact of Commissural and Coronary Alignment in Coronary Cannulation Following TAVR with Evolut Fx

The new valve Evolut FX has shown better commissural alignment vs. its predecessor Evolut Pro+. Prior studies have already shown commissure alignment facilitates post...

TRISCEND II: Transcatheter Replacement vs. Medical Treatment for Tricuspid Regurgitation

The EVOQUE device is designed with an intra-annular sealing system that provides excellent anatomical compatibility and an adaptable shape. It is currently available in...